Advertisement

First Edition

November 13, 2018

November 09, 2018

November 08, 2018

November 07, 2018

November 06, 2018

November 02, 2018

  • Chronic Borrelia burgdorferi infection triggers NKT lymphomagenesis
    Rémy Robinot, Emmanuel Bachy, Sammara Chaubard, Mirjam Urb, Sylvain Carras, Emilie Bardel, Dimitri Chartoire, Alexandra Traverse-Glehen, Patrice N. Marche, Gilles Salles, Benoit Jaulhac and Laurent Genestier

November 01, 2018

October 31, 2018

  • Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in mice
    Jennifer J. Tsai, Enrico Velardi, Yusuke Shono, Kimon V. Argyropoulos, Amanda M. Holland, Odette M. Smith, Nury L. Yim, Uttam K. Rao, Fabiana M. Kreines, Sophie R. Lieberman, Lauren F. Young, Amina Lazrak, Salma Youssef, Ya-Yuan Fu, Chen Liu, Cecilia Lezcano, George F. Murphy, Il-Kang Na, Robert R. Jenq, Alan M. Hanash, Jarrod A. Dudakov and Marcel R.M. van den Brink

October 30, 2018

October 29, 2018

  • Sub-clonal TP53 copy number is associated with prognosis in multiple myeloma
    Vallari Shah, David C. Johnson, Amy L. Sherborne, Sidra Ellis, Frances M. Aldridge, Julie Howard-Reeves, Farzana Begum, Amy Price, Jack Kendall, Laura Chiecchio, Suvi Savola, Matthew W. Jenner, Mark T. Drayson, Roger G. Owen, Walter M. Gregory, Gareth J. Morgan, Faith E. Davies, Richard S. Houlston, Gordon Cook, David A. Cairns, Graham Jackson and Martin F. Kaiser

October 26, 2018

October 25, 2018

October 23, 2018

October 22, 2018

  • Unrelated donor vs HLA-haploidentical alpha/beta T-cell and B-cell depleted HSCT in children with acute leukemia
    Alice Bertaina, Marco Zecca, Barbara Buldini, Nicoletta Sacchi, Mattia Algeri, Francesco Saglio, Cesare Perotti, Anna Maria Gallina, Valentina Bertaina, Edoardo Lanino, Arcangelo Prete, Walter Barberi, Manuela Tumino, Claudio Favre, Simone Cesaro, Francesca Del Bufalo, Mimmo Ripaldi, Stella Boghen, Gabriella Casazza, Marco Rabusin, Adriana Balduzzi, Franca Fagioli, Daria Pagliara and Franco Locatelli
  • Mechanisms of receptor shedding in platelets
    Samantha J. Montague, Robert K. Andrews and Elizabeth E. Gardiner

October 19, 2018

October 17, 2018

October 15, 2018

October 12, 2018

  • Temporal auto-regulation during human PU.1 locus SubTAD formation
    Daniel Schuetzmann, Carolin Walter, Boet van Riel, Sabrina Kruse, Thorsten König, Tabea Erdmann, Alexander Tönges, Eric Bindels, Andre Weilemann, Claudia Gebhard, Klaus Wethmar, Chiara Perrod, Julia Minderjahn, Michael Rehli, Ruud Delwel, Georg Lenz, Stefan Gröschel, Martin Dugas and Frank Rosenbauer

October 11, 2018

October 10, 2018

October 09, 2018

  • Inflammatory signals directly instruct PU.1 in HSCs via TNF
    Martin Etzrodt, Nouraiz Ahmed, Philipp S. Hoppe, Dirk Loeffler, Stavroula Skylaki, Oliver Hilsenbeck, Konstantinos D. Kokkaliaris, Hans-Michael Kaltenbach, Jörg Stelling, Claus Nerlov and Timm Schroeder

October 04, 2018

  • Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma
    Laurent Garderet, Frederique Kuhnowski, Benoit Berge, Murielle Roussel, Martine Escoffre-Barbe, Ingrid Lafon, Thierry Facon, Xavier Leleu, Lionel Karlin, Aurore Perrot, Philippe Moreau, Gerald Marit, Anne-Marie Stoppa, Bruno Royer, Carine Chaleteix, Mourad Tiab, Carla Araujo, Pascal Lenain, Margaret Macro, Eric Voog, Lofti Benboubker, Olivier Allangba, Eric Jourdan, Frederique Orcsini-Piocelle, Sabine Brechignac, Jean-Richard Eveillard, Karim Belhadj, Marc Wetterwald, Brigitte Pegourie, Arnaud Jaccard, Jean-Claude Eisenmann, Sylvie Glaisner, Mohamad Mohty, Cyrille Hulin, Herve Avet Loiseau, Claire Mathiot and Michel Attal
  • The phase 3 DUO trial: duvelisib versus ofatumumab in relapsed and refractory CLL/SLL
    Ian W. Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Árpád Illés, Gabriel Etienne, Julio Delgado, Bryone J. Kuss, Constantine S. Tam, Zoltán Gasztonyi, Fritz Offner, Scott Lunin, Francesco Bosch, Matthew S. Davids, Nicole Lamanna, Ulrich Jaeger, Paolo Ghia, Florence Cymbalista, Craig A. Portell, Alan P. Skarbnik, Amanda F. Cashen, David T. Weaver, Virginia M. Kelly, Barry Turnbull and Stephan Stilgenbauer

October 03, 2018

  • TLT-1 is a Prognostic Indicator in ALI/ARDS and Prevents Tissue Damage in the Lungs in a Mouse model
    Jessica Morales-Ortíz, Victoria Deal, Fiorella Reyes, Gerónimo Maldonado-Martínez, Nahomy Ledesma, Franklin Staback, Cheyanne Croft, Amanda Pacheco, Humberto Ortiz-Zuazaga, C. Christian Yost, Jesse W. Rowley, Bismark Madera, Alex St. John, Junmei Chen, Jose Lopez, Matthew T. Rondina, Robert Hunter, Angela Gibson and A. Valance Washington
  • IG-MYC-positive neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
    Rabea Wagener, Cristina López, Kortine Kleinheinz, Julia Bausinger, Sietse M. Aukema, Inga Nagel, Umut H. Toprak, Julian Seufert, Janine Altmüller, Holger Thiele, Christof Schneider, Julia Kolarova, Jeongbin Park, Daniel Hübschmann, Eva M. Murga Penas, Hans G. Drexler, Andishe Attarbaschi, Randi Hovland, Eigil Kjeldsen, Michael Kneba, Udo Kontny, Laurence de Leval, Peter Nürnberg, Ilske Oschlies, David Oscier, Brigitte Schlegelberger, Stephan Stilgenbauer, Wilhelm Wössmann, Matthias Schlesner, Birgit Burkhardt, Wolfram Klapper, Elaine S. Jaffe, Ralf Küppers and Reiner Siebert
  • FLT3 pathway is a potential therapeutic target for PRC2 mutated T cell acute lymphoblastic leukemia
    Jingliao Zhang, Yingchi Zhang, Man Zhang, Chao Liu, Xiaoming Liu, Jie Yin, Peng Wu, Xiaojuan Cheng, Wenyu Yang, Li Zhang, Ye Guo, Yao Zou, Yumei Chen, Youjia Cao, Tao Cheng and Xiaofan Zhu

Pages